A general assessment of the safety of HMG CoA reductase inhibitors (statins).
about
Statin-induced myopathy: the two faces of Janus.Prevalence of musculoskeletal pain and statin use.Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety.Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis.Qualitative analysis of therapeutic light effects on global function in Alzheimer's disease.Modulated expression of genes associated with NO signal transduction contributes to the cholesterol-lowering effect of electro-acupuncture.
P2860
A general assessment of the safety of HMG CoA reductase inhibitors (statins).
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A general assessment of the safety of HMG CoA reductase inhibitors (statins).
@ast
A general assessment of the safety of HMG CoA reductase inhibitors (statins).
@en
A general assessment of the safety of HMG CoA reductase inhibitors
@nl
type
label
A general assessment of the safety of HMG CoA reductase inhibitors (statins).
@ast
A general assessment of the safety of HMG CoA reductase inhibitors (statins).
@en
A general assessment of the safety of HMG CoA reductase inhibitors
@nl
prefLabel
A general assessment of the safety of HMG CoA reductase inhibitors (statins).
@ast
A general assessment of the safety of HMG CoA reductase inhibitors (statins).
@en
A general assessment of the safety of HMG CoA reductase inhibitors
@nl
P1476
A general assessment of the safety of HMG CoA reductase inhibitors (statins).
@en
P2093
Donald M Black
P2888
P356
10.1007/S11883-002-0060-0
P577
2002-01-01T00:00:00Z
P6179
1011401273